The following is a summary of “Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma, ...

Researchers assessed whether early albumin use among patients with septic shock and kidney impairment upon hospital admission reduced in-hospital mortality or the need for renal replacement ...

This new patent protects the use of Imeglimin for type-2 diabetic patients with moderate to severe renal impairment until 2039. The granting of the patent further supports ongoing discussions ...

The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

THREE of the most dangerous medicines in the world have been revealed – and millions of Brits already use them. A cold and ...

PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral ...

Such a strategy would offer the possibility of multiorgan therapy in diseases characterized by multiorgan impairment, such as type 2 diabetes. I present the evidence that renal dysfunction is a ...

If approved by the EMA, mavorixafor would be the first drug indicated for patients with WHIM syndrome in Europe, a population ...

In analyses that were adjusted for potential confounders, rates of major bleeding did not differ significantly between enoxaparin and UFH recipients, regardless of the degree of renal impairment.

Conclusion: New Indications for Fenofibrate in Microvascular Disease, & Dosing Issues Current guidelines recommend dose reduction in renal impairment, but these thresholds may be too restrictive ...